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BfR welcomes the scientific criteria of the European Commission for 
identifying endocrine disruptors 
 
BfR Communication No 015/2016, 17 June 2016 
 
The European Commission has presented a draft on how endocrine-disrupting chemical 
substances (“endocrine disruptors”) contained in the active ingredients of pesticides and 
biocides can be identified using harmonised scientific criteria. The definition of these criteria 
is a binding foundation for the regulation of endocrine-disrupting substances in order to 
warrant a high level of protection for consumers. 
 
The draft considers suggestions on hazard identification of endocrine-disrupting substances 
which scientists developed in April in the course of an international conference organised by 
BfR and held in Berlin. According to these suggestions, a comprehensive scientific analysis 
with regard to the definition of the WHO must be carried out when identifying such 
substances, and the insights must be weighted based on their conclusiveness, (weight-of-
evidence approach). 
 
The Federal Institute for Risk Assessment (BfR) has recommended for many years that for 
endocrine-disrupting substances the principle of “one substance – one assessment” must 
apply. The institute is of the opinion that the assessment criteria which the European 
Commission has recommended for pesticides and biocides should be applicable to all 
naturally occurring and synthetically produced substances that have a negative effect on the 
body’s hormone system.  
 
BfR recommends that harmonised technical guidelines are developed in order to enable 
transparent and safe identification of chemical substances. In order to ensure a high level of 
protection, a given endocrine disruptor should be identified on the basis of the weight-of-
evidence approach which, among other things, takes into account the quality, reliability, 
reproducibility and conclusiveness of the scientific evidence. 
 
BfR welcomes that, in addition to the mentioned criteria, the communication of the European 
Commission also lists a series of measures and their funding in order to support research 
and international cooperation, as well as the development of testing methods. 
 
The European Commission has presented a draft on how harmonised criteria for the 
identification of endocrine disruptors can be defined in the areas of pesticides and biocides. 
The definition of such criteria is a precondition for a standardised science-based approach to 
the identification and regulation of endocrine-disrupting chemical substances. The draft is 
based on the definition of endocrine disruptors of the World Health Organisation (WHO). In 
its draft, the Commission took into account the scientific consensus on the definition of 
endocrine disruptors as well as the principles of identification of these substances. This 
consensus had been developed and published on the occasion of a conference attended by 
scientists from a range of different disciplines that had been organised by BfR and held in 
Berlin in April.1 
 
BfR is acting on the assumption that the presented criteria based on the fundamental 
principle “One substance – one assessment” can be applied to all naturally occurring and 
                                                
1 The BfR publishes a workshop report on the expert meeting on endocrine disruptors: http://www.bfr.bund.de/cm/349/the-BfR-
publishes-workshop-report-based-on-the-expert-meeting-on-endocrine-disruptors.pdf  
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synthetically produced substances in order to minimise exposure to endocrine disruptors 
overall. Endocrine disruptors can have severe effects on health and the environment, and 
they are already banned for use in pesticides and biocides. The goal now is to be able to 
regulate them for other products as well. For this purpose, the substances must be identified 
based on scientific criteria which are implemented in law. 
 
The criteria for identifying endocrine disruptors can offer a high level of protection for human 
health and the environment provided that the identification of an endocrine disruptor 
considers all relevant scientific insights and that these insights are weighted in accordance 
with their conclusiveness (weight-of-evidence approach). To ensure that this is the case, the 
aspects of consistency, specificity or limit dose must be defined in detail. The Commission 
subscribes to the broad scientific consensus which states that the potency of a substance 
should not be considered when identifying endocrine disruptors. In contrast, its potency must 
be taken into account when assessing the actual risk posed by endocrine disruptors.2 
 
However, for the purpose of the two legal acts in the areas of pesticides and biocides, BfR 
considers the development and alignment of harmonised technical guidelines for practicable 
decisions of all EU authorities to be essential. In line with the communication of the 
Commission, these guidelines can then serve as a basis for transparent and safe 
identification of chemical substances. In order to provide a high level of protection, the 
identification of endocrine disruptors should be based on the weight-of-evidence approach. 
This notably means that the quality, reliability, reproducibility and conclusiveness of scientific 
evidence must be taken into consideration in accordance with internationally agreed study 
protocols (in-vivo studies or adequately validated alternative testing systems that enable 
prediction of harmful effects in human and animals as well as in-vivo, in-vitro and 
mechanistic studies to determine endocrine effects). The specificity of the effect and the limit 
dose are also incorporated in this robust systematic test procedure. BfR acts on the 
assumption that in developing these guidelines, the consensus paper adopted at the 
workshop in April can offer valuable support. 
 
BfR especially welcomes that over and above the mentioned criteria, the communication of 
the Commission also contains a list of measures and their funding in order to support 
research and international cooperation as well as the development of testing methods. The 
EU Commission has additionally asked the European Food Safety Authority (EFSA) and the 
European Chemical Agency (ECHA) to jointly investigate whether individual approved 
substances for which indications exist that they have endocrine disrupting properties can be 
identified as endocrine disruptors based on the presented criteria. 
 
 
Background information on the WHO definition of endocrine disruptors and adverse 
effects: 
 
The scientific criteria recommended by the European Commission are based on the 
definition of endocrine disruptors by the World Health Organisation (WHO), on which broad 
consensus exists (BfR 2016).  
 
The WHO defines a substance as an endocrine disruptor if 
 
 it has an adverse effect on human health, 
 it has an endocrine mode of action and 
                                                
2 http://ec.europa.eu/health/endocrine_disruptors/docs/com_2016_350_en.pdf 
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 a causal relationship exists between the adverse and endocrine mode of action 
(WHO/IPCS 2002). 
 
In 2009, adverse effects were defined which the Commission based on the definition from 
the International Programme on Chemical Safety (WHO 2009): “A change in the morphology, 
physiology, growth, development, reproduction or lifespan of an organism, system or 
(sub)population that results in an impairment of functional capacity, an impairment of the 
capacity to compensate for additional stress or an increase in susceptibility to other 
influences.”  
 
 
Further information on the topic of endocrine disruptors can be found on the BfR 
website:  
 
http://www.bfr.bund.de/en/international_expert_meeting_on_endocrine_disruptors-
197246.html  
 
http://www.bfr.bund.de/en/a-z_index/endocrine_disruptors-130013.html  
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About the BfR 
 
The Federal Institute for Risk Assessment (BfR) is a scientifically independent institution 
within the portfolio of the Federal Ministry of Food and Agriculture (BMEL) in Germany. It 
advises the Federal Government and Federal Laender on questions of food, chemical and 
product safety. The BfR conducts its own research on topics that are closely linked to its 
assessment tasks. 
 
This text version is a translation of the original German text which is the only legally binding 
version. 
